DERA Online Training Trial for Community Health Workers
Summary
ClinicalTrials.gov registration NCT07545577 documents a randomized controlled trial evaluating the Dementia Education and Resources for Action (DERA) online training program among community health workers. The intervention targets Alzheimer's disease and related dementia knowledge, stigma reduction, and service-related self-efficacy. This is an administrative registry entry; it does not create compliance obligations or regulatory requirements.
“The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs).”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
This ClinicalTrials.gov registration documents a new randomized controlled trial evaluating the DERA online training program for community health workers. The study focuses on Alzheimer's disease and related dementia education outcomes including knowledge, stigma, and self-efficacy. This registry entry does not create regulatory obligations—compliance officers may note it as administrative documentation of a healthcare workforce training intervention.
Affected parties include healthcare providers employing community health workers and researchers conducting dementia education studies. The entry serves as an administrative record rather than a compliance mandate.
Archived snapshot
Apr 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Randomized Controlld Trial of Dementia Education Resources for Action
N/A NCT07545577 Kind: NA Apr 22, 2026
Abstract
The goal of this intervention trial is to evaluate the effectiveness the online training program Dementia Education and Resources for Action (DERA) in improving Alzheimer's disease and related dementia-(ADRD) knowledge, stigma, and service-related self-efficacy among community health workers (CHWs). We hypothesize that participants who have completed the DERA will have improved ADRD knowledge and self-efficacy in related service and reduced stigma against ADRD and people affected.
Conditions: Alzheimer's Disease and Related Dementia
Interventions: DERA Online Training Program
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.